ACSL4 predicts rapid kidney function decline in patients with diabetic kidney disease
Open Access
- 13 March 2025
- journal article
- endocrinology
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1499555
Abstract
Background: Ferroptosis of kidney tubular epithelial cells contributes to the pathogenesis of diabetic kidney disease (DKD). An increase in the enzyme long-chain fatty acid CoA ligase 4 (ACSL4) favors ferroptosis. However, the association between ACSL4 in renal tubules and kidney outcomes of patients with DKD is unknown.Methods: To investigate the predictive property of ACSL4 in rapid kidney function decline in patients with DKD, a retrospective cohort of 72 biopsy-proven DKD patients were enrolled and followed up for a median of 23 months. Tubular expression levels of ACSL4 in the renal biopsy specimens from 72 DKD patients and 12 control subjects were measured using immunohistochemistry staining. The associations between the ACSL4 level and clinical characteristics as well as rapid kidney function decline defined as an estimated glomerular filtration rate (eGFR) slope ≤ -5 ml/min/1.73m2/year were analyzed.Results: ACSL4 was mainly expressed in tubular epithelial cells. The tubular ACSL4 expression levels in the DKD patients were significantly higher than those in the control subjects. ACSL4 was positively correlated with proteinuria and negatively correlated with albumin and hemoglobin at the time of the renal biopsy. During the follow-up time period, the median eGFR slope of these DKD patients was -2.30 ml/min/1.73m2/year. ACSL4 was negatively correlated with the eGFR slope. The top tertile of baseline ACSL4 was found to identify the subjects with DKD who were at high risk for rapid kidney function decline and a similar significant relationship was found using ACSL4 levels as a continuous variable.Conclusions: ACSL4 was associated with a rapid progression of DKD and may serve as a novel pathological biomarker.Keywords
This publication has 29 references indexed in Scilit:
- GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024
- Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complicationActa Diabetologica, 2023
- Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathwayFree Radical Biology and Medicine, 2022
- Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidenceKidney International, 2022
- Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathyFree Radical Biology and Medicine, 2021
- XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injuryCell Death & Disease, 2020
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseCell, 2017
- Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failureCellular and Molecular Life Sciences, 2017
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Chapter 2: Definition, identification, and prediction of CKD progressionKidney International Supplements, 2013